AtriAN Medical

Developer of electrophysiology and structural heart devices designed to treat patients suffering from complex chronic cardiac, stroke and arrhythmia risk diseases. The company's devices are built around custom left atrial appendage occluder implants that provide synergistic modules like cardiac monitoring, ablation, or both modules, enabling medical professionals to offer cost-benefit treatments without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.

Developer of connected intravascular medical device designed to help facilitate the treatment of cardiac arrhythmia. The company utilizes artificial intelligence (AI) and real-time tissue analysis through advanced four-dimensional imaging and improves structural heart interventions, enabling doctors to perform cardiac treatments that improve outcomes for patients, increase procedural safety, and reduce the cost to the healthcare system.

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.